Please use this identifier to cite or link to this item: http://hdl.handle.net/1/509
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChopra, Hitesh
dc.contributor.authorKumar, Sandeep
dc.contributor.authorVandana, Vandana
dc.contributor.authorArora, Sandeep
dc.date.accessioned2015-03-09T06:40:57Z
dc.date.accessioned2017-12-19T10:15:32Z-
dc.date.available2015-03-09T06:40:57Z
dc.date.available2017-12-19T10:15:32Z-
dc.date.issued2014-05-30
dc.identifier.issnPrint 2321-2217
dc.identifier.issnOnline 2321-2225
dc.identifier.urihttp://dspace.chitkara.edu.in/xmlui/handle/1/509
dc.identifier.urihttp://hdl.handle.net/1/509-
dc.description.abstractPharmacogenomics is the scientific study which explains individual variability of drug targets and to explore the genetic basis for such changes. With the completion of human genomic study, clear relation could now be established between the drug response in relation to a person’s genome. Pharmacogenomics, also known as personalized medicine, uses the person’s genome to determine the dose and dosage regimen, so that therapy could be optimized. As with the techniques like DNA microarray technologies person’s response to a therapy can be predicted and new therapies could be assigned. In the present review, the current technologies, and past significance has been discussed.en_US
dc.language.isoenen_US
dc.subjectPharmacogenomicsen_US
dc.subjectpersonalized medicineen_US
dc.subjectDNA Microarrayen_US
dc.titlePharmacogenomics: Applications in Drug Discovery and Pharmacotherapyen_US
dc.typeArticleen_US
Appears in Collections:JPTRM Volume 2 Number 1 (May - 2014)

Files in This Item:
File Description SizeFormat 
21004_JPTRM_Hitesh Chopra.pdf122.76 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.